¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-21
±³À°ÀÏÀÚ : 2023-04-21
±³À°Àå¼Ò : ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë

±³À°ÁÖÁ¦ : 2023³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-2277-1919  

À̸ÞÀÏ : stroke@stroke.or.kr

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í Á¤È¸¿ø(»çÀüµî·Ï 50,000, ¿¬È¸ºñ+»çÀüµî·Ï 120,000¿ø, ÇöÀåµî·Ï 60,000¿ø)/ Á¤È¸¿ø Áß ÀüÀÓÀÇ, °øº¸ÀÇ, ±ºÀÇ°ü(»çÀüµî·Ï 30,000, ¿¬È¸ºñ+»çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 40,000¿ø)/ ÁØȸ¿ø, ÀϹÝȸ¿ø(»çÀüµî·Ï 30,000, ¿¬È¸ºñ+»çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 40,000¿ø)/ ºñȸ¿ø(»çÀüµî·Ï 110,000¿ø, ÇöÀåµî·Ï 120,000¿ø)/ ºñȸ¿ø Áß °£È£»ç(»çÀüµî·Ï 60,000¿ø, ÇöÀåµî·Ï 70,000¿ø)/ Á¤È¸¿ø Áß È¸ºñ¹Ì³³È¸¿ø(»çÀüµî·Ï 130,000¿ø, ÇöÀåµî·Ï 140,000¿ø)

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 08:50~09:00 Opening Remark ±èÀÀ±Ô(´ëÇѳúÁ¹ÁßÇÐȸ ȸÀå)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 09:00~09:25 Perfusion-weighted imaging ÀÌÁ¤À±(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 09:25~09:50 Genetic testing ÀÌ°ÇÁÖ(°í·ÁÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 09:50~10:15 Long-term cardiac monitoring and PFO ÀåÁØ¿µ(¿ï»êÀÇ´ë ½Å°æ°ú)

Åä·Ð 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 10:15~10:30 Panel discussion ȲÀçÃá, ±èÁØ¿±, ±èÁß±¸(°æºÏÀÇ´ë ½Å°æ°ú, ¼­¿ïÀÇ´ë ½Å°æ°ú, Á¦ÁÖÀÇ´ë ½Å°æ°ú)

ÈÞ½Ä 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 10:30~10:50 Break ( )

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 10:50~11:20 Inflammation - the new stroke risk factor and treatment target Peter Kelly(University College Dublin)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 11:20~11:50 Recent advances in moyamoya disease ¹æ¿À¿µ(¼º±Õ°üÀÇ´ë ½Å°æ°ú)

±âŸ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 11:50~12:20 General Assembly ( )

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 12:20~12:50 Long-term antiplatelet therapy for stroke patients ±èÁ¤¹Î(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 12:50~13:20 ROSETTA-Stroke, a Randomized Controlled Trial: Moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin for target low-density lipoprotein cholesterol goal achievement in patients with recent ischemic stroke È«±Ù½Ä(ÀÎÁ¦ÀÇ´ë ½Å°æ°ú)

ÈÞ½Ä 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 13:20~13:40 Break ( )

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 13:40~14:00 Atrial fibrillation (beyond oral anticoagulation) ¿ÀÀÏ¿µ(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 14:00~14:20 Blood pressure control Kaznori Toyoda(National Cerebral and Cardiovascular Center)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 14:20~14:40 Treatment of DM for CVD prevention ¼Û¼±¿Á(°Çº¸°ø´Ü Àϻ꺴¿ø ½Å°æ°ú)

Åä·Ð 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 14:40~15:00 Panel discussion À̹οì, ±è¿µ¼­, °­Çö±¸(ÇѸ²ÀÇ´ë ½Å°æ°ú, ¿ø±¤ÀÇ´ë ½Å°æ°ú, ÀüºÏÀÇ´ë ½Å°æ°ú)

ÈÞ½Ä 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 15:00~15:20 Break ( )

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 15:20~15:40 Diagnostic cerebral angiography: How and When, basic anatomy ÀåÀ±°æ(ÀÌÈ­ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 15:40~16:00 Devices used in neurointervention ±èº¸±Ô(°í·ÁÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 16:00~16:20 Process and procedures in mechanical thrombectomy ¹éÀåÇö(¼º±Õ°üÀÇ´ë ½Å°æ°ú)

Åä·Ð 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 16:20~16:40 Panel discussion °ûµ¿¼®, ¹ÚÇüÁ¾, ½Åµ¿¿ì, ¹ÚÁ¤Áø(µ¿±¹ÀÇ´ë ½Å°æ°ú, °è¸íÀÇ´ë ½Å°æ°ú, ÀÌÈ­ÀÇ´ë ½Å°æ°ú, °Ç±¹ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 16:40~17:00 Periprocedural complication during reperfusion therapy ¹ÚÁ¤Áø(°Ç±¹ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 17:00~17:20 Access site complications ȲÁøÈ£(°Ç±¹ÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 17:20~17:40 Blood pressure management after reperfusion therapy Á¤¿äÇÑ(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 17:40~18:00 Periprocedural antithrombotics ±ÇµÎÇõ(¿µ³²ÀÇ´ë ½Å°æ°ú)

Åä·Ð 04¿ù 21ÀÏ ±×·£µåÇϾæÆ® ¼­¿ï ±×·£µåº¼·ë 18:00~19:00 Poster Presentation Professor-Led Poster Tour ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇѳúÁ¹ÁßÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ Ãá°è Çмú´ëȸ(1ÀÏÂ÷) : 2023-04-22
´ÙÀ½±Û ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ CMFS KOREA 2023(Day1) : 2023-04-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 36 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷